Pulmonx Corp. (LUNG)
2.06
-0.02
(-0.96%)
USD |
NASDAQ |
Sep 09, 13:58
Pulmonx Shareholders Equity (Quarterly) : 39.20M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.20M |
| March 31, 2026 | 45.76M |
| December 31, 2025 | 54.12M |
| September 30, 2025 | 60.03M |
| June 30, 2025 | 69.09M |
| March 31, 2025 | 77.67M |
| December 31, 2024 | 85.81M |
| September 30, 2024 | 93.92M |
| June 30, 2024 | 101.18M |
| March 31, 2024 | 110.50M |
| December 31, 2023 | 118.32M |
| September 30, 2023 | 125.74M |
| June 30, 2023 | 133.95M |
| March 31, 2023 | 143.93M |
| Date | Value |
|---|---|
| December 31, 2022 | 154.01M |
| September 30, 2022 | 163.48M |
| June 30, 2022 | 172.18M |
| March 31, 2022 | 182.14M |
| December 31, 2021 | 193.24M |
| September 30, 2021 | 202.83M |
| June 30, 2021 | 209.92M |
| March 31, 2021 | 216.62M |
| December 31, 2020 | 226.13M |
| September 30, 2020 | 0.71M |
| June 30, 2020 | -205.76M |
| March 31, 2020 | |
| December 31, 2019 | -187.38M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.73M |
| Total Liabilities (Quarterly) | 75.54M |
| Debt to Equity Ratio | 1.434 |
| Current Ratio | 4.319 |
| Net Debt Paydown Yield | 0.26% |